Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Enterprise Ethereum Alliance (EEA) is a global, member-led non-profit organization focused on accelerating the adoption of Ethereum blockchain technology for enterprise use. Established in 2017, the EEA develops open-source standards and technical specifications to ensure interoperability and security across business-focused blockchain applications. The organization operates several industry-specific working groups, including a dedicated Healthcare Working Group that explores blockchain solutions for clinical trial data, pharmaceutical supply chains, and patient record management. Its membership includes a diverse range of Fortune 500 companies, technology vendors, and academic institutions collaborating to bridge the gap between public Ethereum and private enterprise requirements. By providing a neutral forum for collaboration, the EEA helps organizations implement decentralized technologies while maintaining compliance and privacy standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enterprise Ethereum Alliance.